On Sept 17th-21st, the 2019 annual congress of Chinese society of nephrology was held in Hangzhou international exhibition center.
Biolight Meditech participated in this grand academic congress and shared their latest innovative dialysis products with the international and domestic nephrologists, clinical medical staff, and distributors.
On Sept 20th, Zhongguancun Nephrology & Blood Purification Innovation Alliance and Biolight Meditech jointly held a Standard Innovation Forum and Product Release Conference to strengthen academic exchange in nephrology and discuss the opportunities and challenges in terms of nephrology and hemodialysis.
Biolight Meditech released their latest hemodialysis products in the conference, and hundreds of nephrologists and experts were there to witness this new power arisen in the hemodialysis industry.
The number of dialysis patients is increased dramatically and rapidly over the years. It leads to a flourishing development of Chinese Nephrology and makes the Chinese companies produce high-level technology achievements.
Hence, the innovation of hemodialysis technology plays an important role in Nephrology research and development.
Opening speech given by Mr. Yan Jinyuan, CEO of Biolight Meditech
Biolight Meditech introduced the industrys prospect of dialysis technology
In the conference, Biolight Meditech released the new product DF210 dialysis fluid filter and PES dialyzer. It breaks down technical barriers and monopoly from foreign companies and improves the international competitiveness of Chinese hemodialysis.